Narikazu Boku Selected Research

Chemoradiotherapy

1/2024	Long-term outcomes after non-curative endoscopic resection for esophageal squamous cell carcinoma followed by additional chemoradiotherapy.
1/2023	Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts.
4/2021	Correction to: Long‑term outcomes of patients with recurrent squamous cell carcinoma of the esophagus undergoing salvage endoscopic resection after definitive chemoradiotherapy.
1/2021	Long-term outcomes of patients with recurrent squamous cell carcinoma of the esophagus undergoing salvage endoscopic resection after definitive chemoradiotherapy.
1/2020	Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy.
10/2019	Gastric mucosal injury and hemorrhage after definitive chemoradiotherapy for locally advanced esophageal cancer.
7/2019	Chemoradiotherapy for Local Recurrence of Rectal Cancer: A Single Center Study of 18 Patients.
3/2019	Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy for unresectable sinonasal undifferentiated carcinoma: Two cases of report.
1/2018	Patterns of Relapse after Definitive Chemoradiotherapy in Stage II/III (Non-T4) Esophageal Squamous Cell Carcinoma.
1/2017	Clinical Outcomes of Resectable Esophageal Cancer with Supraclavicular Lymph Node Metastases Treated with Curative Intent.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Narikazu Boku Research Topics

Disease

132	Stomach Neoplasms (Stomach Cancer) 05/2024 - 08/2000
127	Neoplasms (Cancer) 05/2024 - 08/2000
75	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2003
56	Neoplasm Metastasis (Metastasis) 01/2024 - 08/2000
25	Disease Progression 01/2023 - 09/2000
24	Pancreatic Neoplasms (Pancreatic Cancer) 09/2023 - 01/2006
19	Adenocarcinoma 01/2024 - 10/2008
18	Neutropenia 09/2023 - 07/2006
15	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 01/2002
14	Esophageal Squamous Cell Carcinoma 01/2024 - 06/2006
13	Diarrhea 10/2019 - 07/2006
12	Ascites 01/2023 - 10/2008
12	Anorexia 01/2022 - 01/2008
11	Nausea 05/2024 - 01/2008
11	Carcinoma (Carcinomatosis) 02/2021 - 10/2003
10	Lymphatic Metastasis 01/2024 - 09/2000
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2021 - 07/2003
8	Hemorrhage 10/2019 - 04/2002
7	Febrile Neutropenia 09/2023 - 04/2008
7	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2006
7	Squamous Cell Carcinoma of Head and Neck 06/2015 - 07/2007
6	Hypertension (High Blood Pressure) 01/2024 - 12/2009
6	Thrombocytopenia (Thrombopenia) 01/2021 - 11/2009
6	Colonic Neoplasms (Colon Cancer) 01/2020 - 11/2012
5	Vomiting 05/2024 - 08/2012
5	Proteinuria 01/2024 - 11/2009
5	Anemia 01/2024 - 04/2010
5	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023 - 03/2014
5	Rectal Neoplasms (Rectal Cancer) 07/2019 - 04/2003
5	Fatigue 05/2015 - 04/2008
5	Biliary Tract Neoplasms (Biliary Tract Cancer) 09/2013 - 11/2007
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 06/2023 - 07/2008
4	Infections 01/2023 - 05/2013
4	Neuroendocrine Carcinoma 10/2022 - 09/2014
4	Leukopenia 01/2022 - 05/2013
4	Exanthema (Rash) 01/2020 - 08/2013
3	Linitis Plastica 10/2023 - 01/2019
3	Brain Neoplasms (Brain Tumor) 08/2023 - 12/2005

Drug/Important Bio-Agent (IBA)

66	Fluorouracil (Carac)FDA LinkGeneric 11/2023 - 08/2000
46	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 09/2000
44	Irinotecan (Camptosar)FDA LinkGeneric 03/2024 - 08/2000
43	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024 - 04/2006
26	Leucovorin (Folinic Acid)FDA Link 03/2024 - 04/2006
20	Bevacizumab (Avastin)FDA Link 04/2024 - 08/2007
20	NivolumabIBA 01/2024 - 12/2017
19	PlatinumIBA 01/2024 - 07/2007
19	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2002
19	Gemcitabine FDA Link 01/2019 - 12/2005
16	Paclitaxel (Taxol)FDA LinkGeneric 11/2021 - 08/2000
15	Trastuzumab (Herceptin)FDA Link 01/2024 - 02/2010
15	S-1 plus cisplatinIBA 01/2024 - 12/2008
15	Docetaxel (Taxotere)FDA Link 01/2024 - 01/2006
12	Capecitabine (Xeloda)FDA Link 07/2022 - 12/2008
11	Cetuximab (Erbitux)FDA Link 04/2024 - 05/2008
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 01/2002
9	Panitumumab (Vectibix)FDA Link 05/2022 - 05/2008
8	ErbB Receptors (EGF Receptor)IBA 09/2023 - 01/2002
8	Immune Checkpoint InhibitorsIBA 01/2023 - 10/2019
8	Monoclonal AntibodiesIBA 01/2022 - 01/2006
8	TegafurIBA 01/2020 - 01/2003
6	trifluridine tipiracil drug combinationIBA 03/2024 - 10/2015
6	RamucirumabIBA 08/2023 - 07/2017
5	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2024 - 02/2013
5	Carcinoembryonic AntigenIBA 09/2023 - 10/2008
5	taxaneIBA 08/2023 - 12/2009
5	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2006
5	AntibodiesIBA 08/2022 - 12/2017
5	human ERBB2 proteinIBA 01/2022 - 01/2014
5	Taxoids (Taxanes)IBA 04/2020 - 01/2006
5	Epidermal Growth Factor (EGF)IBA 01/2020 - 04/2012
5	UracilIBA 01/2020 - 01/2003
5	Methotrexate (Mexate)FDA LinkGeneric 10/2013 - 08/2000
4	afliberceptIBA 03/2024 - 08/2013
4	folfirinoxIBA 09/2023 - 10/2014
4	Antineoplastic Agents (Antineoplastics)IBA 07/2022 - 08/2000
4	AntiemeticsIBA 01/2022 - 08/2012
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2000
4	Alanine Transaminase (SGPT)IBA 01/2020 - 04/2013
3	EmeticsIBA 05/2024 - 04/2016
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2024 - 07/2015
3	Circulating Tumor DNAIBA 09/2023 - 12/2016
3	SteroidsIBA 01/2023 - 01/2021
3	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2019
3	AlbuminsIBA 01/2023 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2019
3	Etoposide (VP 16)FDA LinkGeneric 10/2022 - 09/2000
3	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2022 - 01/2002

Therapy/Procedure

166	Drug Therapy (Chemotherapy) 05/2024 - 09/2000
84	Therapeutics 01/2024 - 08/2000
31	Chemoradiotherapy 01/2024 - 01/2002
27	Adjuvant Chemotherapy 11/2023 - 09/2000
21	Gastrectomy 01/2024 - 09/2000
19	Radiotherapy 08/2023 - 04/2003
12	Neoadjuvant Therapy 05/2024 - 01/2003
9	Aftercare (After-Treatment) 01/2024 - 01/2014
7	Combination Drug Therapy (Combination Chemotherapy) 12/2013 - 01/2006
5	Metastasectomy 01/2019 - 04/2013
4	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 04/2010
4	Immunotherapy 01/2023 - 01/2019
4	Salvage Therapy 01/2022 - 07/2003